{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Neonatal cholestasis",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_cholestyramine",
          "name": "Cholestyramine"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_ursodeoxycholic_acid",
          "name": "Ursodeoxycholic acid"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_rifampicin",
          "name": "Rifampicin"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_amiodarone",
          "name": "Amiodarone"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_cyclosporine",
          "name": "Cyclosporine"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_aminoglycosides",
          "name": "Aminoglycosides"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_tetracyclines",
          "name": "Tetracyclines"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_azathioprine",
          "name": "Azathioprine"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_isotretinoin",
          "name": "Isotretinoin"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_sodium_phenylbutyrate",
          "name": "Sodium phenylbutyrate"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_ketoconazole",
          "name": "Ketoconazole"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_ot_cholestyramine",
          "type": "Target",
          "label": "Off-target Cholestyramine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_cholestyramine",
          "type": "Pathway",
          "label": "Risk Pathway Cholestyramine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_cholestasis",
          "type": "Phenotype",
          "label": "Adverse Phenotype Cholestasis",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_ursodeoxycholic_acid",
          "type": "Target",
          "label": "Off-target Ursodeoxycholic Acid",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_ursodeoxycholic_acid",
          "type": "Pathway",
          "label": "Risk Pathway Ursodeoxycholic Acid",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_ursodeoxycholic_acid",
          "type": "Phenotype",
          "label": "Adverse Phenotype Ursodeoxycholic Acid",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_cholestyramine",
          "target": "n_ot_cholestyramine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致非靶器官的毒性反应"
        },
        {
          "source": "n_ot_cholestyramine",
          "target": "n_rp_cholestyramine",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与风险通路相关"
        },
        {
          "source": "n_rp_cholestyramine",
          "target": "n_adv_cholestasis",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致胆汁淤积"
        },
        {
          "source": "n_adv_cholestasis",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若存在这些风险，则胆道适应症减益显著"
        },
        {
          "source": "drug_ursodeoxycholic_acid",
          "target": "n_ot_ursodeoxycholic_acid",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致非靶器官的毒性反应"
        },
        {
          "source": "n_ot_ursodeoxycholic_acid",
          "target": "n_rp_ursodeoxycholic_acid",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与风险通路相关"
        },
        {
          "source": "n_rp_ursodeoxycholic_acid",
          "target": "n_adv_ursodeoxycholic_acid",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致胆汁淤积"
        },
        {
          "source": "n_adv_ursodeoxycholic_acid",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若存在这些风险，则胆道适应症减益显著"
        }
      ],
      "merge": [],
      "set_weights": [],
      "conflict_hotspots": []
    },
    "counterclaims": [
      {
        "id": "K1",
        "text": "可能对胆囊和肝脏功能造成潜在不良影响",
        "confidence": "medium"
      },
      {
        "id": "K2",
        "text": "对胆汁流动及胆道适应症影响不明确",
        "confidence": "medium"
      }
    ],
    "assumptions_challenged": [
      "假设药物对胆汁淤积的作用是单向有效",
      "假设不会对肝脏造成额外负担"
    ],
    "falsification_tests": [
      "是否存在证据显示胆汁淤积不改善？",
      "对比常见药物与胆道适应症真实成效的研究"
    ],
    "next_focus_for_pi": [
      "要求 Proponent 针对胆道适应症的不良反应提供更多证据",
      "确认其他药物的合适性与安全性"
    ]
  }
}